Oxygen chambers could save lives from Flesh-Eating bacteria

NCT ID NCT07489274

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding hyperbaric oxygen treatment (breathing pure oxygen in a pressurized chamber) to standard care can lower the death rate in people with severe, fast-spreading soft-tissue infections. About 1,480 adults with surgically confirmed infection will be randomly assigned to receive either standard care alone or standard care plus hyperbaric oxygen. The main goal is to see if the oxygen treatment improves survival within 30 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NECROTIZING SOFT TISSUE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Antwerpen

    RECRUITING

    Antwerp, Edegem, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.